In Mexico City, more than 3 million people have received the Sputnik V vaccine, making it the most widely used vaccine in the city. Three million vaccines represent 40% of all coronavirus vaccines delivered in the city, suggests Eduardo Clark, director general of the Agencia Digital de Innovación Pública (ADIP). Mexico became the first country in North America to approve the Russian-made vaccine Sputnik V on February 2, 2021.
According to reports from Noticieros Televisa, the Mexico City administration also announced on February 11, 2022 that people between the ages of 30 and 39 will receive the Sputnik V vaccine with AstraZeneca, after previously approving it for people between the ages of 40 and 49. year. Meanwhile, Mexico is currently dealing with a huge wave of COVID, with more than 1,000 deaths on Thursday, the country set a new record for the fourth wave of the coronavirus pandemic.
Sputnik V Produces Larger, Longer-Lasting Immune Response Against COVID
A recent study conducted at the Lazzaro Spallanzani National Institute of Infectious Diseases in Italy stated that the Sputnik V vaccine promotes the production of antibodies capable of neutralizing Omicron more than twice as well as 2 doses of the Pfizer vaccine. Sputnik V produces a larger and longer lasting immune response against COVID including the Omicron variant than many other vaccines, which is enhanced by the Sputnik Light booster.
The first component of the Sputnik V vaccine, Sputnik Light has been approved in over 30 countries with a combined population of over 2.5 billion people, while Sputnik V has been approved in 71 countries with a combined population of over four billion people. Previous research, notably in Argentina, has shown that the Sputnik Light booster can improve protection in circumstances where other vaccines are ineffective.
3.8 million Russians vaccinated
The vaccine was created by the Gamaleya Institute, with support from the Russian Direct Investment Fund. Based on statistics of 3.8 million Russians who have been vaccinated, the Russian-made vaccine has received the second highest number of domestic regulatory approvals in the world, with an estimated 97.6% efficacy, according to Sputnik. Recently, Argentine President Alberto Fernández said he preferred the Russian-made Sputnik V vaccine over other vaccines and had three doses of the vaccine.